Pulmonary surfactant associated protein C
Showing 1 - 25 of >10,000
Lung Diseases, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactant Trial in Saint Louis
Recruiting
- Lung Diseases
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 22, 2022
hsCAR and MAFLD: A Cross-sectional Study
Recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- +2 more
- high-sensitivity C-reactive protein to albumin ratio
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Aug 2, 2023
Chronic Lung Disease of Prematurity, Respiratory Distress Syndrome in Premature Infant, Bronchopulmonary Dysplasia Trial
Not yet recruiting
- Chronic Lung Disease of Prematurity
- +2 more
- Recombinant fragment of human surfactant protein D (rfhSP-D)
- (no location specified)
Jun 6, 2023
Genetic Regulation of Surfactant Deficiency
Completed
- Respiratory Distress Syndrome, Newborn
-
Saint Louis, MissouriSt. Louis Children's Hospital
Jun 4, 2021
Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquin)
Recruiting
- Surfactant Dysfunction
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Mar 14, 2022
Pulmonary Hypertension, COPD Trial in United States (Inhaled NO delivered via INOpulse DS-C Device, Placebo delivered via
Completed
- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease
- Inhaled NO delivered via INOpulse DS-C Device
- Placebo delivered via INOpulse DS-C Device
-
Jasper, Alabama
- +42 more
Jul 13, 2022
Hypertrophic Cardiomyopathy Trial in United States (TN-201)
Not yet recruiting
- Hypertrophic Cardiomyopathy
- TN-201
-
Boston, Massachusetts
- +6 more
Apr 18, 2023
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Aurora, Colorado
- +4 more
Jan 21, 2022
Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial
Recruiting
- Advanced Malignant Solid Neoplasm
- +8 more
- Imatinib Mesylate
- Ipilimumab
-
Houston, TexasM D Anderson Cancer Center
Aug 1, 2022
Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Barotrauma
- Blood and bronchoalveolar fluid collection and analysis
- Chest CT scan
-
Cagliari, Italy
- +3 more
Aug 17, 2023
COPD Trial in Philadelphia (Quercetin)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
-
Philadelphia, PennsylvaniaNathaniel Marchetti
Aug 15, 2023
COVID-19 Respiratory Outcomes Registry
Active, not recruiting
- Covid19
- Questionnaires and Patient Reported Outcomes (PROs)
- +10 more
-
Saint Louis, Missouri
- +3 more
Oct 11, 2022
Pulmonary Arterial Hypertension, Pulmonary Hypertension, Interstitial Lung Disease Trial in Germany, United States (Bardoxolone
Completed
- Pulmonary Arterial Hypertension
- +11 more
- Bardoxolone methyl
- Placebo
-
Phoenix, Arizona
- +31 more
Nov 12, 2021
Bronchopulmonary Dysplasia, Chronic Pulmonary Insufficiency of Prematurity Trial in Roma (Poractant Alfa Intratracheal
Recruiting
- Bronchopulmonary Dysplasia
- Chronic Pulmonary Insufficiency of Prematurity
- Poractant Alfa Intratracheal Suspension [Curosurf]
-
Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Dec 4, 2021
Preterm Birth, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal Trial in Zurich (Surfactant nebulisation)
Completed
- Preterm Birth
- +2 more
- Surfactant nebulisation
-
Zurich, SwitzerlandDepartment of Neonatology, University Hospital Zurich
Nov 21, 2022
Respiratory Distress Syndrome, Bronchopulmonary Dysplasia Trial in Roma (Ventilator for High-frequency Oscillatory Ventilation
Recruiting
- Respiratory Distress Syndrome
- Bronchopulmonary Dysplasia
- Ventilator for High-frequency Oscillatory Ventilation (HFOV)
- Less invasive surfactant administration (LISA)
-
Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Jan 25, 2023
Respiratory Distress Syndrome, Newborn Trial in United States (CHF5633, Poractant alfa)
Completed
- Respiratory Distress Syndrome, Newborn
- CHF5633
- Poractant alfa
-
Mobile, Alabama
- +22 more
Jul 19, 2021
Interstitial Lung Disease, Surfactant Dysfunction Trial in Shanghai (Hydroxychloroquine)
Not yet recruiting
- Interstitial Lung Disease
- Surfactant Dysfunction
-
Shanghai, Shanghai, ChinaChildren's hospital of Fudan University
Jan 9, 2023
SARS CoV 2 Infection, Alveolar; Injury, Children Trial in Istanbul
Completed
- SARS CoV 2 Infection
- +3 more
-
Istanbul, TurkeyHaseki Training and Research Hospital
Nov 17, 2022
Type 2 Diabetes Trial in Spain (liraglutide, )
Diabetes, Type 2, Preterm Birth, Pregnancy, High Risk Trial in Birmingham (Sliding Scale Insulin, Up-Titration of Home Insulin,
Recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Sliding Scale Insulin
- +3 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Dec 7, 2022
Respiratory Distress Syndrome in Premature Infant Trial (Surfactant administration following lung mechanics assessment in
Not yet recruiting
- Respiratory Distress Syndrome in Premature Infant
- Surfactant administration following lung mechanics assessment in addition to clinical assessment
- Surfactant administration following clinical assessment
- (no location specified)
Mar 28, 2023
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Surfactant Dysfunction, Infant Trial in Vienna (Prone positioning)
Recruiting
- Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
- +2 more
- Prone positioning
-
Vienna, AustriaMedical University of Vienna
Aug 22, 2022